2018
DOI: 10.1016/j.cobeha.2018.04.013
|View full text |Cite
|
Sign up to set email alerts
|

The role of ovarian steroids in affective disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
19
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
1
1

Relationship

1
6

Authors

Journals

citations
Cited by 21 publications
(20 citation statements)
references
References 69 publications
0
19
0
Order By: Relevance
“…The scope of this article is limited to the basics needed to initiate clinical practice and research work in this area. Especially interested readers can complement this primer with other in-depth epidemiological and methodological reviews (Eisenlohr-Moul et al, 2017;Hantsoo & Epperson, 2015;Schiller, Johnson, Abate, Schmidt, & Rubinow, 2016;Wei, Schiller, Schmidt, & Rubinow, 2018).…”
Section: Premenstrual Disorders 2 Premenstrual Disorders: a Primer Anmentioning
confidence: 99%
See 3 more Smart Citations
“…The scope of this article is limited to the basics needed to initiate clinical practice and research work in this area. Especially interested readers can complement this primer with other in-depth epidemiological and methodological reviews (Eisenlohr-Moul et al, 2017;Hantsoo & Epperson, 2015;Schiller, Johnson, Abate, Schmidt, & Rubinow, 2016;Wei, Schiller, Schmidt, & Rubinow, 2018).…”
Section: Premenstrual Disorders 2 Premenstrual Disorders: a Primer Anmentioning
confidence: 99%
“…Several lines of investigation are focused on altered luteal phase serotonergic function in PMDD (Roca et al, 2002), altered function of the GABA-A receptor and its response to GABAergic progesterone metabolites (MacKenzie & Maguire, 2014;Martinez et al, 2016), and, most recently, altered cellular gene expression relevant to hormone processing (Dubey et al, 2017). Several expert, up-to-date reviews are available for those who wish to read further about the state of the knowledge in this small but growing area (Schiller et al, 2016;Wei et al, 2018). However, for the purposes of this primer, the critical point is that PMDD is caused by an abnormal neurobiological sensitivity to normal hormone changes across the menstrual cycle, and not abnormal or disordered reproductive hormones or function.…”
Section: Biological Mechanisms Of Pmddmentioning
confidence: 99%
See 2 more Smart Citations
“…Several neuroimaging studies have suggested a neurofunctional basis for hormonally-related behavioral phenomena (for review see refs. 7 , 8 ). In PMDD, the luteal (symptomatic) phase of the menstrual cycle has been associated with altered task-related activations in the medial and lateral orbitofrontal cortex (OFC), amygdala 9 , dorsolateral prefrontal cortex (DLPFC) 10 , insula and medial prefrontal cortex 11 , 12 .…”
Section: Introductionmentioning
confidence: 99%